Discovery Chemistry Congress Keynote Speakers

Mark Bradley Professor of Therapeutic Innovation, Precision Healthcare University Research Institute, Queen Mary University of London Mark received his doctorate from the University of Oxford in 1989, followed by post-doctoral studies at Harvard and returning to the UK as a Royal Society University Research Fellow (University of Southampton). In 1997 he was made a Professor of Combinatorial Chemistry setting up the UK’s Centre for Combinatorial Chemistry. In 2005 he moved to the University of Edinburgh, where he was Director of a £15M Interdisciplinary Research Collaboration in the area of Optical Molecular Imaging (Proteus 2014-2023) and a Doctorial Training Centre (60PhD) in Optical Imaging with Entrepreneurship. In Aug 2023 he moved to Queen Mary University of London as Professor of Therapeutic Innovation and part of the Precision Healthcare university Research Institute. He held an ERC Advanced Grant on “SmartMaterials” for cellular control. He is a co-founder of Ilika Technologies (2004) (which floated on AIMS in 2010), DestiNA Technologies (2010) and Edinburgh Molecular Imaging (2014) and Biocaptiva (2021).
Rathnam Chaguturu Founder and CEO/Senior Director, SRI International Rathnam Chaguturu is the Founder & CEO of iDDPartners, a nonprofit think-tank focused on pharmaceutical innovation. He has more than thirty-five years of experience in academia and industry, managing new lead discovery projects and forging collaborative partnerships with academia, disease foundations, nonprofits, and government agencies.. He is the Founding President of the International Chemical Biology Society, a Founding Member of the Society for Biomolecular Sciences, and Editor-in-Chief of the journal, Combinatorial Chemistry and High Throughput Screening. He serves on several editorial- and scientific advisory boards, recipient of several awards, and is a sought-after speaker at major national and international conferences, passionately advocating the virtues of collaborative partnerships in addressing the pharmaceutical innovation crisis. ‘Collaborative Innovation in Drug Discovery: Strategies for Public and Private Partnerships,’ edited by Rathnam with the Foreword by Ferid Murad, the 1998 Nobel Prize winner in Medicine, has just been published by Wiley.